1172-10-7Relevant academic research and scientific papers
Investigation on bile acid receptor regulators. Discovery of cholanoic acid derivatives with dual G-protein coupled bile acid receptor 1 (GPBAR1) antagonistic and farnesoid X receptor (FXR) modulatory activity
Sepe, Valentina,Renga, Barbara,Festa, Carmen,Finamore, Claudia,Masullo, Dario,Carino, Adriana,Cipriani, Sabrina,Distrutti, Eleonora,Fiorucci, Stefano,Zampella, Angela
, p. 59 - 67 (2015/12/24)
Bile acids, the end products of cholesterol metabolism, activate multiple mechanisms through the interaction with membrane G-protein coupled receptors including the bile acid receptor GPBAR1 and nuclear receptors such as the bile acid sensor, farnesoid X receptor (FXR). Even if dual FXR/GPBAR1 agonists are largely considered a novel opportunity in the treatment of several liver and metabolic diseases, selective targeting of one of these receptors represents an attractive therapeutic approach for a wide range of disorders in which dual modulation is associated to severe side effects. In the present study we have investigated around the structure of LCA generating a small library of cholane derivatives, endowed with dual FXR agonism/GPBAR1 antagonism. To the best of our knowledge, this is the first report of bile acid derivatives able to antagonize GPBAR1.
Farnesoid X-activated receptor agonists
-
Page/Page column 11, (2008/06/13)
The invention relates to compounds of formula (I) in which n, R3, R4, R5, R6, R10, R13, R17, X, Y, and Z are defined above. The invention also relates to pharmaceutical compositions each containing an effective amount of one or more compounds of formula (I) and a pharmaceutically acceptable carrier.
